TABLE 1.
Protein | Molecular Mass (kDa) | Proteotypic Peptide | Concentration Range (μM) | LQC (μM) | MQC (μM) | HQC (μM) |
ApoA-I | 28.1 | ATEHLSTLSEK | 1–100 | 1 | 25 | 100 |
ApoA-II | 9.3 | SPELQAEAK | 0.5–50 | 0.5 | 10 | 50 |
ApoA-IV | 43.4 | SELTQQLNALFQDK | 0.5–50 | 0.5 | 10 | 50 |
ApoA-V | 38.9 | VQELQEQLR | 0.01–1 | 0.01 | 0.25 | 1 |
ApoB48 | 240.8 | LSQLQTYMI | 0.01–1 | 0.01 | 0.25 | 1 |
ApoB100 | 512.9 | ATGVLYDYVNK | 0.1–10 | 0.1 | 2.5 | 10 |
ApoC-I | 6.6 | TPDVSSALDK | 0.05–5 | 0.05 | 1 | 5 |
ApoC-II | 8.2 | TAAQNLYEK | 0.25–25 | 0.25 | 5 | 25 |
ApoC-III | 8.8 | GWVTDGFSSLK | 0.25–25 | 0.25 | 5 | 25 |
ApoC-IV | 11.5 | ELLETVVNR | 0.05–5 | 0.05 | 1 | 5 |
ApoD | 19.3 | VLNQELR | 0.1–10 | 0.1 | 2.5 | 10 |
ApoE | 34.2 | LGPLVEQGR | 0.1–10 | 0.1 | 2.5 | 10 |
ApoE2 | 34.2 | CLAVYQAGAR | 0.1–10 | 0.1 | 2.5 | 10 |
ApoE4 | 34.2 | LGADMEDVR | 0.1–10 | 0.1 | 2.5 | 10 |
ApoE2/E3 | 34.2 | LGADMEDVCGR | 0.1–10 | 0.1 | 2.5 | 10 |
ApoE3/E4 | 34.2 | LAVYQAGAR | 0.1–10 | 0.1 | 2.5 | 10 |
ApoF | 17.4 | SGVQQLIQYYQDQK | 0.05–5 | 0.05 | 1 | 5 |
ApoH | 36.3 | ATVVYQGER | 0.1–10 | 0.1 | 2.5 | 10 |
ApoJ | 50.1 | ELDESLQVAER | 0.1–10 | 0.1 | 2.5 | 10 |
ApoL1 | 41.1 | VAQELEEK | 0.05–5 | 0.05 | 1 | 5 |
ApoL1 (G0) | 41.1 | LNILNNNYK | 0.05–5 | 0.05 | 1 | 5 |
ApoL1 (G1) | 41.1 | LNMLNNNYK | 0.05–5 | 0.05 | 1 | 5 |
ApoL1 (G2) | 41.1 | LNILNNK | 0.05–5 | 0.05 | 1 | 5 |
ApoM | 21.3 | AFLLTPR | 0.1–10 | 0.1 | 2.5 | 10 |
Apo(a) | 240–800 | LFLEPTQADIALLK | 0.005–0.5 | 0.005 | 0.1 | 0.5 |
Apo(a) Kr-IV2 | 12.5 | GTYSTTVTGR | 0.25–25 | 0.25 | 5 | 25 |
Molecular masses were adopted from UniProt (https://www.uniprot.org/) (signal peptides excluded from the calculation). Kr-IV2, apo(a) kringle IV2; LQC, low-concentration QC; MQC, middle-concentration QC; HQC, high-concentration QC.